Thalidomide as an anti-TNF-alpha inhibitor: Implications for clinical use

被引：109

作者：

Klausner, JD

Freedman, VH

Kaplan, G

机构：

[1] Lab. of Cell. Physiol. and Immunol., Rockefeller University, New York

来源：

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1996年 / 81卷 / 03期

关键词：

D O I：

10.1006/clin.1996.0181

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：219 / 223

页数：5

共 36 条

[1]

BARNES PF, 1990, J IMMUNOL, V145, P149

[2] THALIDOMIDE - USE AND POSSIBLE MODE OF ACTION IN REACTIONAL LEPROMATOUS LEPROSY AND IN VARIOUS OTHER CONDITIONS [J].

BARNHILL, RL ;

MCDOUGALL, AC .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1982, 7 (03) :317-323

[3]

Bermudez Luiz E., 1995, Trends in Microbiology, V3, P22, DOI 10.1016/S0966-842X(00)88864-2

[4] THE COMMON MEDIATOR OF SHOCK, CACHEXIA, AND TUMOR NECROSIS [J].

BEUTLER, B ;

CERAMI, A .

ADVANCES IN IMMUNOLOGY, 1988, 42 :213-231

[5]

CLOUSE KA, 1989, J IMMUNOL, V142, P431

[6] TUMOR NECROSIS FACTOR A ACTIVATES HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 THROUGH INDUCTION OF NUCLEAR FACTOR BINDING TO THE NF-KAPPA-B SITES IN THE LONG TERMINAL REPEAT [J].

DUH, EJ ;

MAURY, WJ ;

FOLKS, TM ;

FAUCI, AS ;

RABSON, AB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5974-5978

[7] TUMOR NECROSIS FACTOR-ALPHA INDUCES EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS IN A CHRONICALLY INFECTED T-CELL CLONE [J].

FOLKS, TM ;

CLOUSE, KA ;

JUSTEMENT, J ;

RABSON, A ;

DUH, E ;

KEHRL, JH ;

FAUCI, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) :2365-2368

[8] SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR AS PREDICTORS OF PROGRESSION TO AIDS IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].

GODFRIED, MH ;

VANDERPOLL, T ;

WEVERLING, GJ ;

MULDER, JW ;

JANSEN, J ;

VANDEVENTER, SJH ;

SAUERWEIN, HP .

JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :739-745

[9]

HOBER D, 1989, CLIN EXP IMMUNOL, V78, P329

[10]

IYER CGS, 1971, B WORLD HEALTH ORGAN, V45, P719

← 1 2 3 4 →